Stock Price
384.00
Daily Change
-1.80 -0.47%
Monthly
4.69%
Yearly
-0.85%
Q2 Forecast
362.50

Novozymes reported 249.7M in Selling and Administration Expenses for its fiscal quarter ending in December of 2025.





Selling And Administration Expenses Change Date
Arq USD 2.99M 513K Dec/2025
Avient USD 177.8M 4M Sep/2025
Chemours USD 130M 21M Dec/2025
Coronado Global Resources USD 89.17M 18.87M Dec/2025
Corteva USD 860M 135M Dec/2025
Metallus USD 22.3M 2.2M Dec/2025
Newmont Corporation USD 86M 70M Sep/2025
Novozymes 249.7M 20.1M Dec/2025
SSR Mining USD 17.07M 33.53M Dec/2025